Clinical antifungal activity of thiabendazole.
D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002648:Child; D004821:Epidermophyton; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000188:drug therapy / Q000382:microbiology; D014677:Pharmaceutical Vehicles; D013827:Thiabendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014005:Tinea / Q000188:drug therapy* / Q000382:microbiology; D014006:Tinea Capitis / Q000188:drug therapy; D014008:Tinea Pedis / Q000188:drug therapy / Q000382:microbiology; D014249:Trichophyton
D000935:Antifungal Agents; D014677:Pharmaceutical Vehicles; D013827:Thiabendazole